| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4885c41de83798db9aeb0cee8bac46af |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48 |
| filingDate |
2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79bbd2df73331f5f8aa83d8e9cde1978
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5507c10c6a27e18dc991716176ac727 |
| publicationDate |
2021-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210024557-A |
| titleOfInvention |
Composition and method for diffusing islet cells for insulin production and therapeutic use thereof |
| abstract |
Herein, pancreatic cells are differentiated into CD133/Ki-67-positive activated islet proliferative cells (AIPC) for functional insulin production derived from isolated pancreatic islets, and islet-derived AIPC is tested in vitro using a culture medium containing an active agent. Compositions and methods are disclosed for expanding in culture within. Also disclosed herein is the use of AIPCs for implantation in mammals for in vivo therapy, particularly pancreatic diseases including type 1 diabetes. |
| priorityDate |
2018-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |